CTOs on the Move

MedData Research

www.meddataresearch.com

 
MedData Research is a Walkersville, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Greer Laboratories

Greer Laboratories Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Greer Laboratories Inc. is based in Lenoir, NC. You can find more information on Greer Laboratories Inc. at www.greerlabs.com

Trust RCM

Trust RCM is a Tampa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HealthSmart

For more than 40 years, HealthSmart has offered a wide array of customizable and scalable health plan solutions for self-funded employers. HealthSmart`s comprehensive service suite addresses individual health from all angles. This includes claims and benefits administration, provider networks, pharmacy benefit management services, business intelligence, onsite employer clinics, care management, a variety of health and wellness initiatives and web-based reporting. The Company`s headquarters is in Irving, Texas, with regional hubs throughout the country. HealthSmart`s mission is to improve member health and reduce healthcare costs.

Belong.Life

Belong is the world`s largest digital social network for cancer patients and caregivers.

Berg LLC

BERG is a Boston-based biopharma company focused on taking a bold “back to biology” approach to therapeutic discovery using its unique AI-based Interrogative Biology® platform. This platform combines patient biology and AI-based analytics to engage the differences between healthy and disease environments. The patient’s own biology drives the platform’s results and guides us in the discovery and development of drugs, diagnostics and healthcare applications. Our platform utilizes patient population health data to bring actionable Patient IntelligenceTM to precision medicine applications. For patients this means faster discovery and development of treatments, more effective precision treatments for individuals as well as a reduction in costs to our healthcare systems. BERG has a robust product portfolio in oncology, endocrinology and neurology with mature assets in oncology entering mid and late stage trials. BERG is committed to improving the lives of patients through precision medicine made possible by our innovative platforms.